Episode 14 – Rapid Fire SARS-CoV-2 Vaccines

Welcome back Rounds Table Listeners!

This week we are going back to our Rapid Fire Format to review two papers looking at potential SARS-CoV-2 vaccines.

  1. What is the safety profile and immune system response for a novel SARS-CoV-2 specific vaccine? https://www.nejm.org/doi/full/10.1056/NEJMoa2022483 (1:05-8:44)
  2. What is the safety, reactogenicity, and immunogenicity of a viral vectored coronavirus vaccine that expresses the spike protein of SARS-CoV-2? https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31604-4/fulltext (8:45-20:31)

And for the Good Stuff:

  1. No further description needed, just a guy painting a portrait of himself, painting a portrait of himself, on repeat: https://digg.com/2020/guy-paints-himself-painting-himself-over-and-over
  2. A nice review on why we should drink coffee from NEJM: https://www.nejm.org/doi/full/10.1056/NEJMra1816604

Questions? Comments? Feedback? We’d love to hear from you. @roundstable

Leave a Comment

Your email address will not be published. Required fields are marked *

1 Comment
  • Richard Fralick says:

    A short review on immunology, a reminder about the ‘lasting’ effect from the CD4 T cell response to an immunization, and an informative review of two vaccine studies, notably the one from the Oxford group. Thanks so much!


Michael Fralick

Co-director of the Rounds Table

Michael Fralick is a general internist at Mount Sinai Hospital in Toronto. He completed a Master of Science in Clinical Epidemiology at Harvard University, including a Research Fellowship in Health Policy at the Program On Regulation Therapeutics and Law (PORTAL). His PhD focused on the intersection between machine learning and pharmacoepidemiology.

John Fralick


John Fralick is a general internist at Foothills Medical Centre in Calgary. He completed a Master of Science in Epidemiology at Queen’s University. He completed medical school at the University of Calgary and did his internal medicine training at the University of Toronto.

Republish this article

Republish this article on your website under the creative commons licence.

Learn more